Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company's financial performance showed strong revenue growth and improved gross margins, indicating operational efficiency. Although there was a net loss, it was reduced compared to the previous year. The absence of strategic, risk, or return discussions doesn't negatively impact the sentiment, as the financial metrics alone are positive. The lack of Q&A insights doesn't alter this view. Overall, the earnings report suggests a positive outlook, likely leading to a stock price increase in the short term.
Revenue ElectroCore reported revenue of $3.2 million for Q1 2026, representing a 28% increase year-over-year. The growth was attributed to higher adoption rates of their gammaCore Sapphire device in both the U.S. and international markets.
Gross Margin The gross margin for Q1 2026 was 74%, up from 70% in Q1 2025. This improvement was driven by cost efficiencies in manufacturing and a favorable product mix.
Operating Expenses Operating expenses were $4.5 million in Q1 2026, a 5% increase compared to Q1 2025. The rise was primarily due to increased investment in sales and marketing efforts.
Net Loss Net loss for Q1 2026 was $1.8 million, compared to $2.1 million in Q1 2025. The reduction in net loss was due to higher revenue and improved gross margins.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The selected topic was not discussed during the call.
The company's financial performance showed strong revenue growth and improved gross margins, indicating operational efficiency. Although there was a net loss, it was reduced compared to the previous year. The absence of strategic, risk, or return discussions doesn't negatively impact the sentiment, as the financial metrics alone are positive. The lack of Q&A insights doesn't alter this view. Overall, the earnings report suggests a positive outlook, likely leading to a stock price increase in the short term.
The earnings call reveals strong financial performance with significant revenue growth and improved gross margins. Despite increased expenses, adjusted EBITDA shows improvement. The Q&A highlights strategic growth plans in the VA and DTC channels, with new leadership potentially enhancing federal channel efficiency. While management's guidance was vague on some points, the overall sentiment is positive, supported by partnerships and product launches. These factors suggest a likely positive stock price movement, especially given the strong revenue growth and strategic initiatives.
The earnings call reflects mixed signals. Basic financial performance shows slight improvement in adjusted EBITDA net loss, but there's a delay in profitability. Product development is active, but with uncertainties in TAC-STIM and international revenue. Market strategy is cautious, with some success in VA channels. Expenses are increasing, impacting financial health. Shareholder returns are not addressed. Q&A reveals cautious expansion and litigation issues. Overall, the stock price reaction is likely neutral due to balanced positive and negative elements.
The earnings call presents mixed signals. The VA revenue growth and Truvaga's year-over-year sales increase are positives. However, the sequential decline in Truvaga sales, increased operating expenses, and net loss raise concerns. The Q&A highlights uncertainties around patent litigation and unclear marketing spend impacts. While new product lines and integrations offer potential, the lack of specific guidance and profitability delays temper optimism. Given these factors, the stock price reaction is likely to remain neutral.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.